Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Reproduction ; 134(2): 355-64, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17660244

RESUMO

The release of arachidonic acid from membrane glycerophospholipids through the action of phospholipases (PLs) is the first step in the biosynthesis of prostaglandins (PGs). In reproductive tissues, the most important PLs are cytosolic PLA(2) (cPLA(2)) and types IIA and V of the secretory isoform (sPLA(2)). The aim of this work was to investigate the role of ovarian steroid hormones and oxytocin (OT) in the regulation of rat uterine PLA(2) activity and expression during pregnancy and labor. The activity of sPLA(2) increased near labor, whereas cPLA(2) activity augmented towards the end of gestation. The levels of sPLA(2) IIA and cPLA(2) mRNA showed an increase before labor (P<0.05, day 21), whereas sPLA(2) V mRNA was not regulated during pregnancy. The administration of atosiban (synthetic OT antagonist) together with tamoxifen (antagonist of estrogen receptors) was able to decrease cytosolic and secretory PLA(2) activities, diminish the expression of sPLA(2) IIA and cPLA(2), as well as decrease PGF(2 alpha) production before the onset of labor (P<0.01). The ovarian steroid did not affect PLA(2) during pregnancy. Collectively, these findings indicate that in the rat uterus, both 17beta-estradiol and OT could be regulating the activity and the expression of the secretory and the cytosolic isoforms of PLA(2), thus controlling PGF(2 alpha) synthesis prior to the onset of labor.


Assuntos
Estradiol/fisiologia , Isoenzimas/metabolismo , Trabalho de Parto/metabolismo , Ocitocina/fisiologia , Fosfolipases A2/metabolismo , Útero/enzimologia , Animais , Citosol/enzimologia , Dinoprosta/biossíntese , Dinoprosta/metabolismo , Estradiol/sangue , Antagonistas de Estrogênios/farmacologia , Feminino , Expressão Gênica/efeitos dos fármacos , Isoenzimas/genética , Mifepristona/farmacologia , Ocitocina/sangue , Fosfolipases A2/genética , Gravidez , Progesterona/antagonistas & inibidores , Progesterona/metabolismo , Ratos , Ratos Wistar , Receptores de Ocitocina/antagonistas & inibidores , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tamoxifeno/farmacologia , Útero/efeitos dos fármacos , Vasotocina/análogos & derivados , Vasotocina/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa